OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dupilumab for atopic dermatitis: a real-world Portuguese multicenter retrospective study
Tiago Torres, Maria João Paiva Lopes, Margarida Gonçalo, et al.
Journal of Dermatological Treatment (2022) Vol. 33, Iss. 5, pp. 2554-2559
Closed Access | Times Cited: 12

Showing 12 citing articles:

Expert consensus on the systemic treatment of atopic dermatitis in special populations
David N. Adam, Melinda Gooderham, Jennifer Beecker, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 37, Iss. 6, pp. 1135-1148
Open Access | Times Cited: 50

A nationwide 104 weeks real‐world study of dupilumab in adults with atopic dermatitis: Ineffectiveness in head‐and‐neck dermatitis
Ida Vittrup, Niels Steen Krogh, Henrik Hedegaard Pliess Larsen, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 37, Iss. 5, pp. 1046-1055
Open Access | Times Cited: 39

Dupilumab-Associated Arthritis: A Dermatology-Rheumatology Perspective
Michael J. Woodbury, Jeffrey S. Smith, Joseph F. Merola
American Journal of Clinical Dermatology (2023) Vol. 24, Iss. 6, pp. 859-864
Closed Access | Times Cited: 7

Opioidergic Signaling—A Neglected, Yet Potentially Important Player in Atopic Dermatitis
Dorottya Ádám, József Arany, Kinga Tóth, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4140-4140
Open Access | Times Cited: 12

Interleukin antagonists for atopic dermatitis: a new era of therapy
Aikaterini Tsiogka, Eleni Paschou, Dimitra Koumaki, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 6, pp. 549-559
Closed Access | Times Cited: 2

Short-, mid- and long-term efficacy of dupilumab in moderate-to-severe atopic dermatitis: a real-world multicentre Italian study of 2576 patients
Silvia Ferrucci, Simona Tavecchio, Carlo Alberto Maronese, et al.
Clinical and Experimental Dermatology (2024)
Open Access | Times Cited: 2

Drug Survival, Retention, and Persistence of Dupilumab in Adults and Adolescents with Atopic Dermatitis: A Narrative Literature Review
Mariateresa Rossi, Silvia Ferrucci, Piergiacomo Calzavara‐Pinton, et al.
Advances in Therapy (2024)
Open Access | Times Cited: 2

Dupilumab in Patients with Atopic Dermatitis: A Multicentric, Long-Term, Real-World Portuguese Study
Tiago Torres, Maria João Cruz, Margarida Gonçalo, et al.
Dermatology and Therapy (2024) Vol. 14, Iss. 8, pp. 2209-2221
Open Access

Arthritis during dupilumab therapy
Elena García‐Zamora, Enrique Gómez de la Fuente, J.L. López‐Estebaranz
Medicina Clínica (English Edition) (2023) Vol. 161, Iss. 8, pp. 365-366
Closed Access | Times Cited: 1

ATOPİK DERMATİT TEDAVİSİNDE BİYOLOJİK İLAÇLAR: LİTERATÜR TARAMASI
Furkan Çalıcıoğlu, Neşecan Çalıcıoğlu, Atıl Avcı, et al.
Journal of Anatolian Medical Research (2024)
Open Access

Systemic Treatments for Atopic Dermatitis in Children and Adolescents: Review of Current Practice and New Treatments
Razan Dodein, Alya Abdul‐Wahab, Piu Banerjee
Apollo Medicine (2023) Vol. 20, Iss. 1, pp. 61-70
Open Access

Artritis secundaria a dupilumab
Elena García‐Zamora, Enrique Gómez de la Fuente, J.L. López‐Estebaranz
Medicina Clínica (2023) Vol. 161, Iss. 8, pp. 365-366
Closed Access

Page 1

Scroll to top